Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pan-cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05693844
What this trial is testing

Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Chinese PLA General Hospital 15
Testing effectiveness (Phase 2)UnknownNCT06055166
What this trial is testing

A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors

Who this might be right for
PARP Inhibitor for Esophageal Squamous Cell Carcinoma
Chongqing University Cancer Hospital 120
Not applicableStudy completedNCT04532645
What this trial is testing

Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK

Who this might be right for
Ovary Cancer
AstraZeneca 342
Not applicableLooking for participantsNCT07404202
What this trial is testing

A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients

Who this might be right for
Pan-tumor(NSCLC, GYN Cancers, BTC and UC)
AstraZeneca 2,100
Not applicableUnknownNCT05693831
What this trial is testing

MyCare-102: Clinical Utility and Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

Who this might be right for
CancerRelapsed CancerRefractory Cancer
Cellworks Group Inc. 730
Not applicableLooking for participantsNCT07504367
What this trial is testing

Large Language Models Assist in Tumor MDT

Who this might be right for
Lung CancerBreast CancerColorectal Cancer+2 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07781449
What this trial is testing

Topical JAK-Inhibition of Early-Stage CTCL

Who this might be right for
Mycosis FungoidesCutaneous T-cell Lymphoma
Aarhus University Hospital 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Early research (Phase 1)Ended earlyNCT01441128
What this trial is testing

-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungAdenocarcinomaCarcinoma, Squamous Cell+1 more
National Cancer Institute (NCI) 20
Not applicableActive Not RecruitingNCT05179824
What this trial is testing

Tempus Priority Study: A Pan-tumor Observational Study

Who this might be right for
Breast CancerProstate CancerBladder Cancer+24 more
Tempus AI 1,000
Early research (Phase 1)Ended earlyNCT03355066
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Biosplice Therapeutics, Inc. 82
Testing effectiveness (Phase 2)UnknownNCT03989310
What this trial is testing

An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Chinese PLA General Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06973564
What this trial is testing

JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

Who this might be right for
Advanced Solid Tumors
Jacobio Pharmaceuticals Co., Ltd. 294
Not applicableUnknownNCT04822792
What this trial is testing

Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT

Who this might be right for
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 11,879
Not applicableLooking for participantsNCT05663515
What this trial is testing

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Who this might be right for
Pancreatic Cancer
AstraZeneca 24,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04872985
What this trial is testing

Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer

Who this might be right for
Breast CancerHormone-receptor Positive Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 140
Not applicableStudy completedNCT02492815
What this trial is testing

PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 1,773
Early research (Phase 1)Study completedNCT03238196
What this trial is testing

Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Vanderbilt-Ingram Cancer Center 35
Early research (Phase 1)Looking for participantsNCT04913285
What this trial is testing

Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Who this might be right for
Solid Tumor, AdultNon-small Cell Lung CancerMelanoma
Pierre Fabre Medicament 400
Not applicableActive Not RecruitingNCT07584044
What this trial is testing

A Pan-Cancer Retrospective Study on the Relationship Between Tumor Microenvironment Composition and Efficacy of Antibody-Based Antitumor Therapy

Who this might be right for
Tumor MicroenvironmentAntibody
Tianjin Medical University Cancer Institute and Hospital 300
Next Page